Latest News

As the Canadian market navigates through policy shifts and global uncertainties, the TSX is on track for its strongest calendar-year return since 2009, rewarding investors who stayed committed during periods of volatility. In this context, understanding what makes a good investment becomes crucial; penny stocks, while an older term, continue to offer intriguing opportunities for growth. These stocks often represent smaller or newer companies that can pair strong financial health with...

Green Cross Health Limited ( NZSE:GXH ) recently posted some strong earnings, and the market responded positively. We...

Cimpress (CMPR) just gave investors a fresh leadership catalyst, with VistaPrint appointing Dave DeSandre as Senior Vice President of North America to steer category strategy, product innovation, and customer experience across its largest market. See our latest analysis for Cimpress. Investors seem to be cautiously warming to that story, with a 30 day share price return of 11.42 percent and a 90 day share price return of 14.81 percent, even though the 1 year total shareholder return remains...

In recent months, MBX Biosciences reported positive topline Phase 2 results for its lead candidate canvuparatide in hypoparathyroidism and completed an upsized US$200 million capital raise, while MPM BioImpact exited its entire position. At the same time, Goldman Sachs initiated coverage with a Sell rating amid concerns about validating MBX’s platform beyond canvuparatide, contrasting with more optimistic peers and sharpening debate over the company’s longer-term pipeline potential. Against...

If you are wondering whether Barrick Mining is still worth considering after its massive run, or if you have already missed the upside, this breakdown will help you cut through the noise and focus on what the numbers say about value. The stock has pulled back slightly in the last week with a -0.2% move, but that comes after a powerful 29.2% climb over 30 days and eye catching gains of 156.2% year to date and 146.5% over the past year that have completely changed how the market is pricing its...

Recently, Cirrus Logic was highlighted as Zacks Bull of the Day after delivering four consecutive earnings beats and seeing analysts raise their earnings estimates, reflecting confidence in its operations and profitability. This recognition underscores how consistent outperformance and improving operating margins can influence analyst sentiment, potentially reshaping expectations for a company already undergoing product and end-market diversification. Next, we will examine how Cirrus Logic's...

UWM Holdings (UWMC) just saw a meaningful insider move, with major shareholder SFS Holding unloading stock and converting paired interests, shortly after mixed third quarter results that beat on revenue but missed on earnings. See our latest analysis for UWM Holdings. At around $5.80, the recent insider sales and mixed earnings land against a backdrop where short term share price returns have been choppy, but the three year total shareholder return remains solidly positive, suggesting...

Sally Beauty Holdings recently reported past fourth-quarter 2025 results that exceeded forecasts for both adjusted diluted earnings per share and revenue, while Senior Vice President Scott C. Sherman sold 15,000 shares of common stock worth about US$244,000 on 1 December 2025. The combination of an earnings beat and insider selling has drawn attention to how investors are weighing operational progress against leadership share disposals and mixed institutional positioning. We’ll now examine...

Invivyd, Inc. recently announced it has identified and nominated VBY329, a potentially best-in-class monoclonal antibody candidate aimed at preventing RSV in neonates, infants, and children, with plans to advance it toward IND readiness by the second half of 2026. This move positions Invivyd to potentially expand beyond its COVID-19 focus into the growing pediatric RSV prophylaxis market, which management cites as a multi-billion dollar global opportunity by 2030. We’ll now examine how...

California Resources (CRC) has landed on investors’ radar after Wells Fargo initiated coverage, alongside a third quarter earnings beat on earnings per share, even as revenue came in lighter than forecasts. See our latest analysis for California Resources. The muted 1 month share price return of 2.3% and slightly negative year to date share price return sit awkwardly against a robust 3 year total shareholder return of about 28%, suggesting momentum is only cautiously rebuilding as investors...

In late November 2025, Allied Gold Corporation reported an exploration and development update for its Kurmuk mine in western Ethiopia, with first-pass drilling at the Urchin Prospect and multiple nearby targets returning higher-than-reserve gold grades and confirming mineralization continuity across a 1,600 m by 500 m multi-lens deposit that remains open at depth and laterally. The company also identified modelled hydrothermal breccias with higher-than-average grades and outlined potential...

Selective Insurance Group (SIGI) has quietly slipped about 16 % year to date, even as its revenue and earnings keep growing. That disconnect sets up an interesting moment to revisit what the current price implies. See our latest analysis for Selective Insurance Group. Over the past year, the share price has drifted lower despite steady premium growth and solid underwriting results. A weak year to date share price return and a negative one year total shareholder return suggest momentum has...

In recent months, TFS Financial has attracted increased interest from institutional investors such as Creative Planning and Geode Capital Management, while also declaring a high-yield quarterly dividend payable on December 16 and reporting quarterly earnings above analyst expectations. These developments, combined with insider share sales and upgrades in analyst ratings, highlight a complex mix of confidence, income appeal, and shifting perceptions around the bank’s prospects. Next, we’ll...

In late November 2025, XPO reported preliminary North American less-than-truckload metrics showing a 5.4% year-over-year drop in tonnage per day, driven by fewer shipments and lighter average loads, highlighting ongoing softness in freight volumes. While these weaker operating trends raise fresh questions about near-term demand, they also test how resilient XPO’s technology- and margin-focused freight strategy can be under pressure. We’ll now examine how this recent 5.4% tonnage decline fits...

CNO Financial Group (CNO) shares have cooled slightly after a strong multi year run, which has some investors asking whether this insurer’s steady earnings growth and income profile still justify leaning in at current levels. See our latest analysis for CNO Financial Group. The share price has eased back to around $40.29 after a softer week and month of trading, yet the year to date share price return remains positive and the multi year total shareholder return signals that longer term...

If you are wondering whether Apellis Pharmaceuticals is a beaten down biotech bargain or a value trap at today’s price, you are not alone. This breakdown is designed to give you a clear, no jargon view of where the value really sits. The stock has bounced about 4.2% over the last week and 11.2% in the last month, even though it is still down roughly 33.1% year to date and 33.7% over the past year. This combination often signals shifting market expectations rather than a simple trend. Recent...

CSX recently disclosed that its fourth-quarter earnings will be reduced by about US$40 million after an October coal train derailment and unrelated aluminum plant fires curtailed coal and automotive shipments, even as intermodal volumes held up. This setback highlights how concentrated exposure to bulk commodities can pressure results even when other parts of the rail network are performing well. We’ll now examine how the expected US$40 million earnings impact reshapes CSX’s investment...

Wix.com (WIX) just delivered an earnings beat, lifted its 2025 revenue outlook, and saw a major institutional investor boost its stake, together with an active buyback that signals managements confidence. See our latest analysis for Wix.com. Even with upbeat earnings, higher 2025 guidance, and the Base44 acquisition strengthening its AI tools, Wix.com’s recent share price return has been weak. Short term pressure contrasts with a stronger three year total shareholder return, suggesting...

Iridium Communications (IRDM) just landed a fresh 5 year contract with the U.S. Space Force worth up to $85.8 million, extending its role in mission critical defense communications. See our latest analysis for Iridium Communications. Even with this new Space Force win and a fresh dividend declaration, the share price has slid sharply this year, with a year to date share price return of negative 40.68 percent and a one year total shareholder return of negative 42.1 percent. This suggests...

In recent days, digital banking platform Dave has come under pressure after insiders, including the CEO and CFO, sold a combined US$91.3 million of stock over the past year and Weiss Ratings downgraded the company from a buy to a hold rating in late November 2025, prompting fresh scrutiny of management’s stance and business risks. What stands out is the contrast between these insider sales and downgrade on one hand, and separate third-party assessments highlighting strong revenue trends,...

Parsons (PSN) just secured a spot on the Defense Threat Reduction Agency’s CTRIC IV contract, a recompete vehicle with a potential 10 year, $3.5 billion ceiling that could shape its long term revenue pipeline. See our latest analysis for Parsons. The CTRIC IV award lands as Parsons’ 90 day share price return of 11.65 percent and 30 day gain of 6.16 percent signal improving momentum, even though the year to date share price return is still negative and the five year total shareholder return of...

Sabine Royalty Trust (SBR) has declared a monthly cash distribution of $0.196670 per unit, payable on December 29 to holders of record as of December 15, putting fresh income front and center for yield focused investors. See our latest analysis for Sabine Royalty Trust. The latest cash distribution lands on a unit price that has already seen a solid year to date 21.13 percent share price return. At the same time, long term total shareholder returns of 298.74 percent over five years suggest...

Eldorado Gold (TSX:ELD) just reported its highest mineral reserve estimate since 2017, and that kind of reserve growth can matter more to long term returns than any single quarterly headline. See our latest analysis for Eldorado Gold. The new reserve milestone lands on top of a strong run, with a 30 day share price return of 16.9 percent and a five year total shareholder return of 166 percent. This signals momentum that long term holders have been rewarded for staying with. If this kind of...

Dynatrace (DT) just rolled out deeper integrations with advanced AWS services and picked up fresh AWS partner awards, putting a spotlight on its AI observability platform and competitive positioning in cloud operations. See our latest analysis for Dynatrace. Despite the strong product momentum, Dynatrace’s share price at $44.31 reflects a softer patch, with an 18.47% year to date share price decline and a 24.42% total shareholder return drop over the past year, even though three year total...